Heart Disease News and Research

Latest Heart Disease News and Research

Enzyme released by mast cells in the lungs could be a new target for asthma

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.

4 Feb 2008

Porous structures help boost integration of host tissue with implants

Results published in FASEB (the journal of the Federation of American Societies for Experimental Biology) by researchers at Columbia University, including Jeremy Mao of the Columbia College of Dental Medicine, demonstrate a novel way of using porous structures as a drug-delivery vehicle that can help boost the integration of host tissue with surgically implanted titanium.

4 Feb 2008

New understanding of ion channel regulation

A study at Rush University Medical Center in Chicago published this week in the online version of Biophysical Journal proposes that bubbles may control the opening and closing of ion channels.

4 Feb 2008

U.S. mental health survey of people with schizophrenia and providers

Mental Health America has released results of the first national online survey to examine overall healthcare in mental health settings from the perspective of both people with schizophrenia and psychiatrists.

31 Jan 2008

Smoking and SIDS

A new study sheds light on the relationship between women who smoke while pregnant or are exposed to second-hand smoke and an increased risk of SIDS to their babies.

30 Jan 2008

Lungs' mast cells could provide new treatment target for asthma, other respiratory disease

30 Jan 2008

Heart transplant standards set too low

Heart surgeons at Johns Hopkins have evidence to support further tightening rather than easing of standards used to designate hospitals that are best at performing heart transplants.

30 Jan 2008

Common drug-releasing coronary stents appear to have similar clinical outcomes

A comparison of use of the first two commercially available drug-releasing coronary stents (for the medications sirolimus and paclitaxel) among patients in "everyday clinical practice" indicates no significant differences for outcomes such as heart attack or cardiac death, according to a study in the January 30 issue of JAMA: The Journal of the American Medical Association.

30 Jan 2008

Carbon monoxide causes direct damage to the heart muscle

Lack of oxygen isn't the only way that carbon monoxide (CO) damages the heart, say researchers at Rhode Island Hospital.

30 Jan 2008

New biodegradable film reduces scarring following open heart surgery

A new, biodegradable film designed to reduce the severity of scarring following open heart surgery in young children appears to be safe and effective, according to researchers attending the annual meeting of the Society of Thoracic Surgeons in Ft. Lauderdale.

30 Jan 2008

New nanomedicine research for prostate cancer

The Prostate Cancer Foundation, largely through the generosity of David H. Koch, has given $5 million to four institutions, including Weill Cornell Medical College, to support novel research in prostate cancer. The gift is one of the largest-ever individual donations for prostate cancer research.

29 Jan 2008

New target found for asthma

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma -- pointing to a potential new target for treatment against the illness.

29 Jan 2008

Collaboration to improve the UK's health

A collaboration between the Universities of Bristol, Cardiff and Swansea has been awarded £5 million by the UK Clinical Research Collaboration (UKCRC) to establish a Centre of Excellence for research into public health.

29 Jan 2008

Oseltamivir resistance in European Influenza viruses

Preliminary surveillance into antiviral drug susceptibility against seasonal flu viruses currently circulating in Europe has revealed that some of the A (H1N1) viruses (13%) have shown resistance to the antiviral drug, oseltamivir.

29 Jan 2008

Smaller pancreatic tumors greatly increase survival odds

The odds of surviving cancer of the pancreas increase dramatically for patients whose tumors are smallest, according to a new study by researchers at Saint Louis University and the M.D. Anderson Cancer Center in Houston - the first study to specifically evaluate the link between tumor size and survival rates for one of the most common and deadly cancers.

28 Jan 2008

Sex, drugs and diet top issues parents want doctors to discuss with kids

When parents bring their children in for routine check-ups many are hoping the doctors and nurse practitioners caring for them will do more than just check blood pressure, listen to their heart and provide any necessary vaccinations.

28 Jan 2008

Evidence strongly supports diuretics as initial metabolic syndrome therapy, especially in black patients

New research shows that in people with high blood pressure as part of metabolic syndrome, a cluster of conditions that increases the risk for heart disease, diuretics offer greater protection against cardiovascular disease, including heart failure, and are at least as effective for lowering blood pressure as newer, more expensive medications.

28 Jan 2008

Malnourishment in young mothers and their babies has consequences well beyond infant health and mortality

Maternal and child under-nutrition have a life-long impact on the health and prospects of the child, potentially affecting future generations.

28 Jan 2008

Celebrex may disrupt heart rhythm

Celebrex, a popular arthritis drug that blocks pain by inhibiting an enzyme known as COX-2, has been shown in laboratory studies to induce arrhythmia, or irregular beating of the heart, via a novel pathway unrelated to its COX-2 inhibition.

25 Jan 2008

M. D. Anderson, AstraZeneca form alliance to advance understanding of cancer-related pain

The University of Texas M. D. Anderson Cancer Center and AstraZeneca (NYSE:AZN) today announced that they will collaborate to help advance understanding of neuropathic pain caused by cancer chemotherapy, a side effect that often limits optimal therapeutic dosing in cancer treatments.

25 Jan 2008